Paediatric HIV-1 infection
Paediatric HIV-1 infection
复制标题
DOI:
10.1016/s0140-6736(99)90249-0
复制
发表时间:
1999-09-01
期刊:
影响因子:
168.9
通讯作者:
Mofenson, LM
中科院分区:
文献类型:
--
作者:
Burns, DN;Mofenson, LM
Advances in the prevention and treatment of paediatric Mother-to-child transmission HIV-l infection have had a huge impact on the Even in developed countries perinatal transmission has incidence and progression of this disease in children in not been eliminated. Some HIV-infected pregnant Europe and North America. Widespread implementation women are still not offered or decline HIV testing, others of three-part zidovudine prophylaxis,’ an increase in receive no prenatal care, and in a few cases zidovudine elective caesarean delivery of HIV-infected women, and prophylaxis fails. 12 Current studies in these countries are the use of combination antiretroviral regimens in focusing on ways to augment the benefit of the three-part children have been temporally associated with a decline zidovudine regimen and to provide alternatives for in paediatric AIDS and increased surviva1. 2, 3 Perinatal women whose HIV-l status is not identified until late in HIV transmission rates as low as l-2% have been pregnancy or at delivery. reported with the combination of antiviral prophylaxis In developing countries, where HIV-l seroprevalence and elective caesarean section. 3-5 among pregnant women is often many times higher than Unfortunately, these advances have had little impact in it is in developed countries, the cost and complexity of the developing world. UNAIDS estimates that every day the full zidovudine regimen limit applicability. Studies in sees 1500 children under 15 years of age become these countries have focused on abbreviated antiretroviral infected, largely by mother-to-child transmission. 6 regimens and non-antiretroviral interventions.